• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Office of Generic Drugs

The Office of Generic Drugs (OGD) is responsible for providing regulatory oversight to expedite the availability of safe, effective, and high-quality generic drugs to patients.  We also provide guidance to regulated industry on a wide variety of clinical, scientific, and regulatory matters relating to generic drugs. We are committed to maintain the public’s confidence in an Agency that continues to meet the ever-changing needs of public health. 


OGD Mission:

To ensure through a scientific and regulatory process, that generic drugs are safe and effective for the American public.



OGD is the interface for abbreviated new drug (ANDA) firms to interact with the Generic Drug Program.


Regulatory Science



News and Announcements





Contact FDA

301-595-1147 Fax
Office of Generic Drugs

Immediate Office

10903 New Hampshire Avenue

Silver Spring, MD 20993